0000899243-22-026846.txt : 20220727
0000899243-22-026846.hdr.sgml : 20220727
20220727163037
ACCESSION NUMBER: 0000899243-22-026846
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220725
FILED AS OF DATE: 20220727
DATE AS OF CHANGE: 20220727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silver Brian M.
CENTRAL INDEX KEY: 0001860597
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40603
FILM NUMBER: 221111403
MAIL ADDRESS:
STREET 1: C/O TSCAN THERAPEUTICS, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TScan Therapeutics, Inc.
CENTRAL INDEX KEY: 0001783328
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825282075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 857-399-9500
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-25
0
0001783328
TScan Therapeutics, Inc.
TCRX
0001860597
Silver Brian M.
C/O TSCAN THERAPEUTICS, INC.
830 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
3.27
2022-07-25
4
A
0
220000
0.00
A
2032-07-24
Voting Common Stock
220000
220000
D
The shares subject to this option vest over 4 years of service following July 25, 2022, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.
/s/ Brian M. Silver
2022-07-27